- Home
- PTGX vs YSS Comparison
PTGX vs YSS Comparison
Compare PTGX & YSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$96.84
N/A
Current Price
$18.98
Company Overview
Basic Information| Metric | PTGX | YSS |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.2B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTGX | YSS |
|---|---|---|
| Price | $96.84 | $18.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $100.17 | $38.33 |
| AVG Volume (30 Days) | 551.4K | ★ 633.8K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $711.26 | $125.85 |
| Revenue Next Year | N/A | $54.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $39.60 | $19.54 |
| 52 Week High | $100.00 | $34.36 |
Technical Indicators
Market Signals| Indicator | PTGX | YSS |
|---|---|---|
| Relative Strength Index (RSI) | 63.95 | 28.48 |
| Support Level | $76.63 | N/A |
| Resistance Level | $100.00 | $29.07 |
| Average True Range (ATR) | 4.24 | 1.55 |
| MACD | 0.39 | -0.45 |
| Stochastic Oscillator | 81.98 | 0.66 |
Price Performance
Historical Comparison PTGX
YSS
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.